Which statement accurately reflects the need for registrations with the DEA?

The statement that separate registrations are needed for various activities is accurate in the context of DEA regulations. In the United States, the Drug Enforcement Administration (DEA) requires different registrations depending on the nature of the activities involving controlled substances. This means that entities wishing to manufacture, distribute, dispense, or conduct research with controlled substances must register separately for each activity.

For instance, a pharmacy dispensing controlled substances operates under a different registration than a manufacturer producing those substances. Similarly, a wholesaler that distributes controlled substances would require a separate registration distinct from those held by pharmacies or manufacturers. This ensures that the DEA can effectively monitor and regulate the various roles and responsibilities of businesses involved with controlled substances, maintaining a clear system of accountability and compliance with federal laws.

Other options do not accurately reflect the nuances of the DEA registration process. For example, stating that all businesses only need one registration overlooks the requirement for multiple registrations based on specific activities. Likewise, saying a single location dispensing controlled substances only needs one registration disregards the potential for other operations, such as manufacturing or research, that could require additional registrations. Finally, suggesting that only manufacturers need registration is incorrect, as all entities involved in the controlled substances supply chain, including pharmacies and wholesalers, must register with the DEA to legally